Malignant arrhythmic mitral valve prolapse: A continuum of clinical challenges from diagnosis to risk stratification and patient management

2Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Mitral valve prolapse (MVP) is a common valvular disease, which may remain a benign condition for a long period of time. However, some patients experience malignant ventricular arrhythmias and sudden cardiac death (SCD). It is still largely unknown how to risk-stratify these patients, and no specific recommendations have been proposed to help the clinical decision-making. We present the case of a young man whose first clinical presentation was an out-of-hospital cardiac arrest and was subsequently diagnosed with MVP. We highlighted the possible risk factors for SCD and the challenges in the clinical management of these patients.

Cite

CITATION STYLE

APA

Yedidya, I., Van Wijngaarden, A. L., & Marsan, N. A. (2021). Malignant arrhythmic mitral valve prolapse: A continuum of clinical challenges from diagnosis to risk stratification and patient management. Journal of Cardiovascular Development and Disease, 8(1), 1–6. https://doi.org/10.3390/jcdd8010002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free